Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 1984;69:955-962

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roubin, G. S.
Right arrow Articles by Harris, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roubin, G. S.
Right arrow Articles by Harris, P. J.

Circulation, Vol 69, 955-962, Copyright © 1984 by American Heart Association

ARTICLES

Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol

GS Roubin, CY Choong, S Devenish-Meares, NN Sadick, PJ Fletcher, DT Kelly and PJ Harris

Eleven patients with severe left ventricular impairment (mean ejection fraction 24%) and moderate impairment of exercise tolerance underwent a double-blind, placebo-controlled, cross-over trial of the orally administered beta-agonist prenalterol. Exercise hemodynamics and tolerance were measured during bicycle and treadmill exercise after 2 weeks of therapy with placebo or prenalterol. Cardiac index, ejection fraction, and stroke work index were not improved and exercise duration and peak oxygen consumption were not significantly different during the two treatments. During prenalterol treatment heart rate during exercise was consistently reduced. These results show that prolonged therapy with prenalterol does not improve hemodynamics or exercise tolerance and is associated with a diminished heart rate response to exercise.


This article has been cited by other articles:


Home page
 CirculationHome page
X.-J. Du, D. J. Autelitano, R. J. Dilley, B. Wang, A. M. Dart, and E. A. Woodcock
{beta}2-Adrenergic Receptor Overexpression Exacerbates Development of Heart Failure After Aortic Stenosis
Circulation, January 4, 2000; 101(1): 71 - 77.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
R. P Steeds and K. S Channer
Drug treatment in heart failure
BMJ, February 14, 1998; 316(7131): 567 - 568.
[Full Text]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1984 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.